Reprogramming the endogenous type III-A CRISPR-Cas system for genome editing, RNA interference and CRISPRi screening in Mycobacterium tuberculosis

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Epidemiology

Medicine

Microbiology

Pathology

Show all topics

DOI

10.1101/2020.03.09.983494

License

CC-BY

Other Formats

PDF